triple agonist glp 1 retatrutide ly3437943 glp-1 gip glucagon mechanism Beyond -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Dual and Triple Gut Peptide

Attend an informational webinar to learn more by signing up HERE

Our mobile IV service brings this powerful therapy directly to you across Pennsylvania, from Philadelphia's Center City to Pittsburgh's suburbs, making it convenient to prioritize your wellness without disrupting your busy schedule

White blood cells help fight infections and protect the body from diseases

Referncias Bibliogrficas Estudos clnicos, cientficos e laudos apresentados pelos fornecedores dos insumos

Many patients administer both on the same day for convenience, while others space them throughout the week based on personal preference and symptom management